The role of emicizumab, a bispecific factor IXa- and factor X-directed antibody, for the prevention of bleeding episodes in patients with hemophilia A

由 Knight, Tristan, Callaghan, Michael U.
發表在 Ther Adv Hematol (2018)

Evaluating venetoclax and its potential in treatment-naïve acute myeloid leukemia

由 Knight, Tristan, Edwards, Holly, Taub, Jeffrey W, Ge, Yubin
發表在 Cancer Manag Res (2019)

Current Management of Pleuropulmonary Blastoma: A Surgical Perspective

由 Knight, Samantha, Knight, Tristan, Khan, Amir, Murphy, Andrew J.
發表在 Children (Basel) (2019)

MAP4K1 expression is a novel resistance mechanism and independent prognostic marker in AML-but can be overcome via targeted inhibition

由 Knight, Tristan E., Edwards, Holly, Taub, Jeffrey W., Ge, Yubin
發表在 EBioMedicine (2021)

Paroxysmal Nocturnal Dyspnea Secondary to Right Ventricular Myxoma: A Novel Presentation of an Unusual Tumor

由 Knight, Tristan E., Shiramizu, Bruce, Ly, Princeton, Thompson, Karen S., Reddy, Venu
發表在 Case Rep Pediatr (2018)

Underdiagnosis of Conditions Associated with Sudden Cardiac Death in Children - Is it the Absence of a Comprehensive Screening Program or a True Low Prevalence?

由 Takiguchi, Marisa, Knight, Tristan, Nguyen, Tin Toan, Limm, Blair, Hayes, Donald, Reddy, Venu, Bratincsak, Andras
發表在 Hawaii J Med Public Health (2016)

Peripheral Primitive Neuroectodermal Tumor and Neurofibromatosis Type 1 in an Adolescent Male

由 Knight, Tristan E., Knight, Samantha W. E., Kyono, Wade, Thompson, Karen, Hicks, John, Shiramizu, Bruce
發表在 Pediatr Blood Cancer (2016)

Simultaneous cotargeting of ATR and RNA Polymerase I transcription demonstrates synergistic antileukemic effects on acute myeloid leukemia

由 Wang, Tingting, Shatara, Margaret, Liu, Fangbing, Knight, Tristan, Edwards, Holly, Wang, Guan, Lin, Hai, Wang, Yue, Taub, Jeffrey W., Ge, Yubin
發表在 Signal Transduct Target Ther (2019)

Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-mutated Acute Myeloid Leukemia

由 Ma, Jun, Zhao, Shoujing, Qiao, Xinan, Knight, Tristan, Edwards, Holly, Polin, Lisa, Kushner, Juiwanna, Dzinic, Sijana H., White, Kathryn, Wang, Guan, Zhao, Lijing, Lin, Hai, Wang, Yue, Taub, Jeffrey W., Ge, Yubin
發表在 Clin Cancer Res (2019)

Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia

由 Li, Xinyu, Su, Yongwei, Madlambayan, Gerard, Edwards, Holly, Polin, Lisa, Kushner, Juiwanna, Dzinic, Sijana H., White, Kathryn, Ma, Jun, Knight, Tristan, Wang, Guan, Wang, Yue, Yang, Jay, Taub, Jeffrey W., Lin, Hai, Ge, Yubin
發表在 Haematologica (2019)

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML

由 Qiao, Xinan, Ma, Jun, Knight, Tristan, Su, Yongwei, Edwards, Holly, Polin, Lisa, Li, Jing, Kushner, Juiwanna, Dzinic, Sijana H., White, Kathryn, Wang, Jian, Lin, Hai, Wang, Yue, Wang, Liping, Wang, Guan, Taub, Jeffrey W., Ge, Yubin
發表在 Blood Cancer J (2021)

The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia

由 Li, Xinyu, Su, Yongwei, Hege, Katie, Madlambayan, Gerard, Edwards, Holly, Knight, Tristan, Polin, Lisa, Kushner, Juiwanna, Dzinic, Sijana H., White, Kathryn, Yang, Jay, Miller, Regan, Wang, Guan, Zhao, Lijing, Wang, Yue, Lin, Hai, Taub, Jeffrey W., Ge, Yubin
發表在 Haematologica (2020)

Comparative Decellularization and Recellularization of Wild-Type and Alpha 1,3 Galactosyltransferase Knockout Pig Lungs: A Model for Ex Vivo Xenogeneic Lung Bioengineering and Tran...

由 Platz, Joseph, Bonenfant, Nicholas R., Uhl, Franziska E., Coffey, Amy L., McKnight, Tristan, Parsons, Charles, Sokocevic, Dino, Borg, Zachary D., Lam, Ying-Wai, Deng, Bin, Fields, Julia G., DeSarno, Michael, Loi, Roberto, Hoffman, Andrew M., Bianchi, John, Dacken, Brian, Petersen, Thomas, Wagner, Darcy E., Weiss, Daniel J.
發表在 Tissue Eng Part C Methods (2016)